Literature DB >> 420768

Antithrombin reactions with alpha- and gamma-thrombins.

T Chang, R D Feinman, B H Landis, J W Fenton.   

Abstract

Human alpha-thrombin with high clotting activity and its proteolyzed derivative gamma-thrombin with virtually no clotting activity reacted in an essentially identical manner with antithrombin. The two enzyme forms bound proflavin with similar constants and showed identical behavior with small substrates. No significant differences were found for the antithrombin reactions (measured by proflavin displacement or active site titration) with respect to kinetics, extent of reaction, or effect of added heparin. The enzyme--antithrombin complexes could not be dissociated with sodium dodecyl sulfate (NaDodSO4) but the NaDodSO4-denatured complexes were dissociated by hydroxylamine treatment. The gamma-thrombin-antithrombin complex has an approximate molecular weight of 75 000 by disc gel electrophoresis as compared with 100 000 for the alpha-complex, consistent with the polypeptide structures of the two proteins. The gamma-thrombin--antithrombin complex did not inhibit clotting catalyzed by alpha-thrombin. In addition, fibrinogen did not affect the reaction of gamma-thrombin with antithrombin or antithrombin--heparin. Thus, the antithrombin and antithrombin--heparin reactions do not involve the fibrinogen recognition sites which are destroyed by proteolytic conversion of alpha-thrombin to the noncoagulant gamma form.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420768     DOI: 10.1021/bi00568a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.

Authors:  F A Ofosu; J W Fenton; J Maraganore; M A Blajchman; X Yang; L Smith; N Anvari; M R Buchanan; J Hirsh
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Thrombospondin fragmentation by alpha-thrombin and resistance to gamma-thrombin.

Authors:  K Takahashi; M Aiken; J W Fenton; D A Walz
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

3.  Cleavage and inactivation of Factor IX by granulocyte elastase.

Authors:  A Takaki; D L Enfield; A R Thompson
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

4.  Tyrosine sulfation modulates activity of tick-derived thrombin inhibitors.

Authors:  Robert E Thompson; Xuyu Liu; Jorge Ripoll-Rozada; Noelia Alonso-García; Benjamin L Parker; Pedro José Barbosa Pereira; Richard J Payne
Journal:  Nat Chem       Date:  2017-03-20       Impact factor: 24.427

5.  Structure-function relationships in human alpha- and gamma-thrombins.

Authors:  L J Berliner
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

6.  [The importance of the plasmatic blood clotting system in the early stages of arterial thrombogenesis (author's transl)].

Authors:  H Zaugg
Journal:  Klin Wochenschr       Date:  1979-12-17

7.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

8.  Thrombin-specific inhibition by and slow cleavage of hirulog-1.

Authors:  J I Witting; P Bourdon; D V Brezniak; J M Maraganore; J W Fenton
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

9.  Interaction of the synthetic antithrombotic peptide P10 with thrombin: a spectroscopy study.

Authors:  Fangyuan Chen; Han Jiang; Wenwei Chen; Guangrong Huang
Journal:  RSC Adv       Date:  2019-06-11       Impact factor: 4.036

10.  Mosquito-Derived Anophelin Sulfoproteins Are Potent Antithrombotics.

Authors:  Emma E Watson; Xuyu Liu; Robert E Thompson; Jorge Ripoll-Rozada; Mike Wu; Imala Alwis; Alessandro Gori; Choy-Theng Loh; Benjamin L Parker; Gottfried Otting; Shaun Jackson; Pedro José Barbosa Pereira; Richard J Payne
Journal:  ACS Cent Sci       Date:  2018-03-28       Impact factor: 14.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.